This article was originally published in The Gray Sheet
Retains restructuring firm Jay Alix & Associates to develop and implement restructuring plans. Also announced are the resignations of Chairman and CEO Shan Padda and Doron Levitas, vice-chariman and secretary; both will retain their positions as directors of the company. A representative of Jay Alix will be appointed acting CEO. The firm plans to report second quarter earnings "as soon as practicable" after auditors complete a previously announced review, but Sabratek was unable to meet the Aug. 20 deadline for its Form 10-Q. The law firm of Cohen, Milstein, Hausfeld & Toll announced Aug. 25 that they have filed a lawsuit against the company in Chicago federal court on behalf of persons who purchased Sabratek's common stock between May 11 and Aug. 23, 1999
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.